As of April 3, 2026, Heartbeam Inc. (BEAT), a developer of remote cardiac diagnostic and monitoring solutions, trades at a current price of $1.18, marking a 3.28% decline in intraday trading. This analysis focuses on key technical levels, recent market context, and potential near-term trading scenarios for the stock, as no recent earnings data has been released to drive fundamental sentiment as of this writing. Over recent weeks, BEAT has traded in a relatively tight range, with technical suppor
BEAT Stock Analysis: Heartbeam Inc. drops 3.28% to $1.18 testing key short-term support
BEAT - Stock Analysis
4956 Comments
1806 Likes
1
Moneka
New Visitor
2 hours ago
A real inspiration to the team.
๐ 124
Reply
2
Hanayo
New Visitor
5 hours ago
I understand the words, not the meaning.
๐ 164
Reply
3
Kaimya
Active Reader
1 day ago
Real-time US stock market capitalization analysis and size classification for appropriate risk assessment and position sizing decisions. We help you understand how company size impacts volatility and expected returns in different market conditions and economic environments. We provide size analysis, volatility by market cap, and size factor returns for comprehensive coverage. Understand size impact with our comprehensive capitalization analysis and size classification tools for risk management.
๐ 178
Reply
4
Gionnie
Experienced Member
1 day ago
Ah, shouldโve checked this earlier.
๐ 129
Reply
5
Thames
Senior Contributor
2 days ago
I read this like it was breaking news.
๐ 140
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.